Drug release coated stent

Claim 2

1 . A stent for implantation in a body comprising a tubular metal body having open ends and an open lattice sidewall structure and a layer on the surface of said sidewall structure, said layer comprising a hydrophobic elastomeric material incorporating an amount of biologically active material therein for timed delivery therefrom.

Claim 3

2 . The device of claim 1 wherein said tubular body is formed of an open braid of filaments of fine metallic wire which is axially deformable for insertion but which resumes a predetermined diameter and length upon relaxation.

Claim 4

3 . The device of claim 2 wherein the metal is selected from the group consisting of stainless steel, titanium alloys including nitinol, tantalum, and cobalt-chrome alloys.

Claim 5

4 . The device of claim 1 wherein said layer is applied as a solvent mixture of uncured polymeric material and finely divided biologically active species and then cured at an elevated temperature.

Claim 6

5 . The device of claim 4 wherein the biostable elastomeric material is selected from the group consisting of silicones, polyurethanes, ethylene vinyl acetate copolymers, polyolefin elastomers, EPDM rubbers and combinations thereof.

Claim 7

6 . The device of claim 1 wherein said elastomeric material is a poly siloxane and wherein said biologically active material is selected from the group consisting of heparin and dexamethasone.

Claim 8

7 . The device of claim 6 wherein said biologically active material is heparin having an average particle size ≦10 microns.

Claim 9

8 . The device of claim 7 wherein the amount of heparin is from about 10% to about 45% of the total weight of the layer.

Claim 10

9 . The device of claim 7 wherein said layer is from about 30 to about 150 μm in thickness.

Claim 11

10 . The device of claim 4 wherein said biologically active species is at least partially soluble in said solvent mixture of uncured polymeric material.

Claim 12

11 . The device of claim 10 wherein said biologically active species is dexamethasone and comprises from about 0.4% to about 45% of the total weight of the layer.

Claim 13

12 . The device of claim 2 wherein said coating adheres to the filaments of fine metallic wire in a manner that preserves said open braid.

Claim 14

13 . The device of claim 6 wherein said coating adheres to the filaments of fine metallic wire in a manner that preserves said open braid.

Claim 15

14 . A tubular stent for implantation in a body lumen location of interest comprising a flexible, elastic open braided tubular body of relatively fine metallic wire, said body being coated with a thin layer of a biostable hydrophobic biologically inactive elastomeric material selected from the group consisting of silicones, polyurethanes, thermoplastic elastomers, ethylene vinyl acetate copolymers, and EPDM rubbers, containing an amount of finely divided biologically active material dispersed therein in a manner that produces a controlled delivery of said biologically active species from said stent upon implantation, said coating adhering to the individual filaments of said braided structure in a manner that preserves said open braided structure.

Claim 16

14 . A tubular stent for implantation in a body lumen location of interest comprising a flexible, elastic open braided tubular body of relatively fine metallic wire, said body being coated with a thin layer of a biostable hydrophobic biologically inactive elastomeric material selected from the group consisting of silicones, polyurethanes, thermoplastic elastomers, ethylene vinyl acetate copolymers, and EPDM rubbers, containing an amount of finely divided biologically active material dispersed therein in a manner that produces a controlled delivery of said biologically active species from said stent upon implantation, said coating adhering to the individual filaments of said braided structure in a manner that preserves said open braided structure.

Claim 17

15 . A stent for implantation in a body comprising a tubular metal body having open ends and an open lattice sidewall structure and a layer on the surface of said sidewall structure, said layer comprising a hydrophobic elastomeric material containing biologically active material therein, the layer adapted to provide long-term delivery of said biologically active material in the body.

Claim 18

15 . A stent for implantation in a body comprising a tubular metal body having open ends and an open lattice sidewall structure and a layer on the surface of said sidewall structure, said layer comprising a hydrophobic elastomeric material containing biologically active material therein, the layer adapted to provide long-term delivery of said biologically active material in the body.

Claim 19

16 . The device of claim 15 wherein the hydrophobic elastomeric material is selected from the group of silicones, polyurethanes, ethylene vinyl acetate copolymers, polyolefin elastomers, and EPDM rubbers and combinations thereof.

Claim 20

17 . The device of claim 15 wherein said elastomeric material is a poly siloxane and wherein said biologically active material is selected from the group consisting of heparin and dexamethasone.

Claim 21

18 . The device of claim 15 wherein said biologically active material is heparin having an average particle size ≦10 microns.

Claim 22

19 . The device of claim 15 wherein said biologically active species is dexamethasone and comprises from about 0.5% to about 10% by weight of said coating.

Claim 23

20 . The device of claim 15 wherein said tubular body is formed of an open braid of filaments of fine metallic wire, and said coating adheres to the filaments of fine metallic wire in a manner that preserves said open braid.